Return to Statistics Toolbox

OPLS-DA analysis for Study ST003412

(Analysis AN005604 )

Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:0.5 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:2.0 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:20 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:4.0 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:50 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:cerulenin | Drug Treatment:6.0 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:NA | Drug Treatment:Control
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:1 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:200 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:20 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:500 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:50 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-2640 | Drug Treatment:5 uM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:1 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:200 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:20 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:500 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:50 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Intracellular | Drug:TVB-3166 | Drug Treatment:5 uM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:0.5 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:2.0 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:20 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:4.0 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:50 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:cerulenin | Drug Treatment:6.0 uM cerulenin
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:NA | Drug Treatment:Control
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:1 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:200 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:20 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:500 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:50 nM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-2640 | Drug Treatment:5 uM TVB-2640
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:1 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:200 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:20 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:500 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:50 nM TVB-3166
Sample source:BT-474 Breast cancer cells | Sample Type:Medium | Drug:TVB-3166 | Drug Treatment:5 uM TVB-3166
Sample source:NA | Sample Type:Blank | Drug:- | Drug Treatment:NA
Sample source:NA | Sample Type:Blank | Drug:NA | Drug Treatment:NA
Sample source:NA | Sample Type:Medium | Drug:NA | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug:- | Drug Treatment:NA
Sample source:NA | Sample Type:QC | Drug:NA | Drug Treatment:NA

  logo